Assessing the opportunity costs of patients with multidrug-resistant organisms in hospitals
Authors:
- 15 December 2017
- journal article
- research article
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 19 (7) , 1009-1017
Abstract
The concept of opportunity cost can be applied to the utilization of hospital beds with special focus on patients colonized or infected with multidrug-resistant organisms. Blocked beds due to isolation measures or increased length of stay may result in opportunity costs if newly arriving patients have to be rejected and the hospital is confronted with revenue foregone. However, the amount of these costs is unclear, since different approaches are used in the literature to determine the respective costs. Our paper develops a concept to assess opportunity costs from the perspective of a hospital.Keywords
This publication has 20 references indexed in Scilit:
- Cost comparison of MRSA screening and management – a decision tree analysisBMC Health Services Research, 2012
- Transmission rates, screening methods and costs of MRSA—a systematic literature review related to the prevalence in GermanyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in EuropePLOS Medicine, 2011
- Hospital safety and complexityBMJ, 2011
- Vancomycin-Resistant Enterococci Outbreak, Germany, and Calculation of Outbreak StartEmerging Infectious Diseases, 2008
- Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) paymentClinical Microbiology and Infection, 2005
- Economics of Preventing Hospital InfectionEmerging Infectious Diseases, 2004
- Additional Costs for Preventing the Spread of Methicillin-Resistant Staphylococcus aureus and a Strategy for Reducing These Costs on a Surgical WardInfection Control & Hospital Epidemiology, 2003
- Eine Kostenanalyse von MRSA-Infektionen auf einer operativen IntensivstationAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 1999
- Economics notes: Opportunity costBMJ, 1999